000 02431 a2200685 4500
005 20250518041155.0
264 0 _c20200422
008 202004s 0 0 eng d
022 _a2213-2619
024 7 _a10.1016/S2213-2600(19)30139-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScagliotti, Giorgio V
245 0 0 _aNintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.
_h[electronic resource]
260 _bThe Lancet. Respiratory medicine
_c07 2019
300 _a569-580 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndoles
_xadministration & dosage
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMesothelioma
_xdrug therapy
650 0 4 _aMesothelioma, Malignant
650 0 4 _aMiddle Aged
650 0 4 _aPemetrexed
_xadministration & dosage
650 0 4 _aPleural Neoplasms
_xdrug therapy
650 0 4 _aProgression-Free Survival
700 1 _aGaafar, Rabab
700 1 _aNowak, Anna K
700 1 _aNakano, Takashi
700 1 _avan Meerbeeck, Jan
700 1 _aPopat, Sanjay
700 1 _aVogelzang, Nicholas J
700 1 _aGrosso, Federica
700 1 _aAboelhassan, Rasha
700 1 _aJakopovic, Marko
700 1 _aCeresoli, Giovanni L
700 1 _aTaylor, Paul
700 1 _aOrlandi, Francisco
700 1 _aFennell, Dean A
700 1 _aNovello, Silvia
700 1 _aScherpereel, Arnaud
700 1 _aKuribayashi, Kozo
700 1 _aCedres, Susana
700 1 _aSørensen, Jens Benn
700 1 _aPavlakis, Nick
700 1 _aReck, Martin
700 1 _aVelema, Derek
700 1 _avon Wangenheim, Ute
700 1 _aKim, Miyoung
700 1 _aBarrueco, José
700 1 _aTsao, Anne S
773 0 _tThe Lancet. Respiratory medicine
_gvol. 7
_gno. 7
_gp. 569-580
856 4 0 _uhttps://doi.org/10.1016/S2213-2600(19)30139-0
_zAvailable from publisher's website
999 _c29704639
_d29704639